Hot Features
プレミアム
Addex Therapeutics Ltd (0QNV)
LSE
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Addex to Present at the 2025 Swiss Equities Baader Conference Geneva, Switzerland, January 8, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on...
Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update Indivior selected GABA B PAM drug candidate for development in substance use disorders (SUD) and starts IND...
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 Nine-month Results Remain On Track for Net Profit Ad Hoc Announcement Pursuant to Art. 53 LR Geneva...
Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update Launched Neurosterix with Perceptive Advisors to accelerate the development of M4PAM...
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 19, 2024 - Addex...
Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Geneva, Switzerland, September 4, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage...
Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 27, 2024...
Addex’s Partner Discontinues ADX71149 development in Epilepsy Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a...
Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS) Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland...
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 3.02 | 3.02 | 3.02 | 21 | 3.02 | DE |
| 4 | 0 | 0 | 3.02 | 3.02 | 3.02 | 6 | 3.02 | DE |
| 12 | 0 | 0 | 3.02 | 3.02 | 3.02 | 605 | 3.02 | DE |
| 26 | 0 | 0 | 3.02 | 3.02 | 3.02 | 753 | 3.02 | DE |
| 52 | 0 | 0 | 3.02 | 3.02 | 3.02 | 1554 | 3.02 | DE |
| 156 | 0 | 0 | 3.02 | 3.02 | 3.02 | 794 | 3.02 | DE |
| 260 | 0 | 0 | 3.02 | 3.02 | 3.02 | 800 | 3.02 | DE |
sab63090
10分前
sab63090
11分前
marcis
13分前
cashclan
14分前
NickyCapone
18分前
Jrod301
25分前
thistraderknowsall
25分前
Wayne R
27分前
budfoxfun
27分前
budfoxfun
28分前
QueenVic
29分前
MasterBlastr
30分前
capgain
31分前
budfoxfun
33分前
jeunke22
36分前
Methinks
37分前
Methinks
39分前
Seminole Red
39分前
Methinks
41分前
capgain
41分前
kenjiroo
42分前
budfoxfun
46分前
Ranb2khz
48分前
S-BEES-BUMBLEBEE
49分前
S-BEES-BUMBLEBEE
51分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
